Back to Search Start Over

Coronary physiology in the catheterisation laboratory: an A to Z practical guide.

Authors :
Fezzi S
Huang J
Lunardi M
Ding D
Ribichini FL
Tu S
Wijns W
Source :
AsiaIntervention [AsiaIntervention] 2022 Oct 06; Vol. 8 (2), pp. 86-109. Date of Electronic Publication: 2022 Oct 06 (Print Publication: 2022).
Publication Year :
2022

Abstract

Coronary revascularisation, either percutaneous or surgical, aims to improve coronary flow and relieve myocardial ischaemia. The decision-making process in patients with coronary artery disease (CAD) remains largely based on invasive coronary angiography (ICA), even though until recently ICA could not assess the functional significance of coronary artery stenoses. Invasive wire-based approaches for physiological evaluations were developed to properly assess the ischaemic relevance of epicardial CAD. Fractional flow reserve (FFR) and later, instantaneous wave-free ratio (iFR), were shown to improve clinical outcomes in several patient subsets when used for coronary revascularisation guidance or deferral and for procedural optimisation of percutaneous coronary intervention (PCI) results. Despite accumulating evidence and positive guideline recommendations, the adoption of invasive physiology has remained quite low, mainly due to technical and economic issues as well as to operator-resistance to change. Coronary image-based computational physiology has been recently developed, with promising results in terms of accuracy and a reduction in computational time, costs, radiation exposure and risks for the patient. Lastly, the integration of intracoronary imaging and physiology allows for individualised PCI treatment, aiming at complete relief of ischaemia through optimised morpho-functional immediate procedural results. Instead of a conventional state-of-the-art review, this A to Z dictionary attempts to provide a practical guide for the application of coronary physiology in the catheterisation laboratory, exploring several methods, their pitfalls, and useful tips and tricks.<br />Competing Interests: W. Wijns received a research grant and honoraria from MicroPort (TARGET AC trial); is the co-founder of Argonauts, an innovation facilitator; and is the senior medical advisor at Rede Optimus Research and Corrib Core Laboratory. S. Tu is a consultant for and received research grants from Pulse Medical. The other authors have no conflicts of interest to declare.

Details

Language :
English
ISSN :
2491-0929
Volume :
8
Issue :
2
Database :
MEDLINE
Journal :
AsiaIntervention
Publication Type :
Academic Journal
Accession number :
36798834
Full Text :
https://doi.org/10.4244/AIJ-D-22-00022